Institute for Legal and Traffic Medicine, University Hospital Heidelberg, Voss-Strasse 2, 69115, Heidelberg, Germany.
Int J Legal Med. 2013 Jan;127(1):69-76. doi: 10.1007/s00414-012-0696-4. Epub 2012 Apr 25.
Z-drugs such as zopiclone are increasingly involved in forensic cases. Its degradation occurs in solvents and biological fluids. It is assumed that hydrolysis largely accounts for the breakdown of zopiclone in aqueous media. Therefore, a stability study in blood at different storage conditions (-20, 4, 20, and 40°C) was performed to establish changes of the drug's concentration with time, also including its degradation product 2-amino-5-chloropyridine (ACP). As removal of the aqueous phase may stabilize molecules that are prone to hydrolysis, it was assessed whether the use of dried blood spots (DBS) may be an alternative for storing and analyzing zopiclone and ACP. Spiked and authentic blood samples and corresponding DBS were analyzed using fully validated LC-MS/MS assays. There was agreement between the measurement of zopiclone from either blood or matching DBS in freshly prepared samples. Results showed that zopiclone was unstable in blood at all storage temperatures except at -20°C. Stability of zopiclone in spiked and authentic blood was increased in DBS compared to matching blood samples stored at the same condition. About 85 % of the initial concentration of zopiclone was still intact in DBS on day 8 at 20°C. ACP was formed from zopiclone in equimolar amounts in both media. Therefore, determination of both zopiclone and ACP may be helpful to estimate the initial concentration in both media. Pre-analytical conditions have a major impact on the recovery of zopiclone from blood. With respect to its known advantages, DBS can be recommended as a valuable alternative for the determination of zopiclone from blood.
Z 类药物(如佐匹克隆)在法医案例中越来越常见。其在溶剂和生物体液中会发生降解。据推测,水解释放大量负责佐匹克隆在水介质中分解。因此,在不同储存条件下(-20、4、20 和 40°C)对血液中的稳定性进行了研究,以确定药物浓度随时间的变化,包括其降解产物 2-氨基-5-氯吡啶(ACP)。由于去除水相可能会稳定易发生水解的分子,因此评估了使用干血斑(DBS)是否可以替代储存和分析佐匹克隆和 ACP。使用完全验证的 LC-MS/MS 分析方法对加标和真实血液样本和相应的 DBS 进行了分析。在新鲜制备的样品中,从血液或匹配的 DBS 测量的佐匹克隆之间存在一致性。结果表明,佐匹克隆在所有储存温度下(-20°C 除外)在血液中均不稳定。与在相同条件下储存的匹配血液样本相比,DBS 中加标和真实血液中佐匹克隆的稳定性增加。在 20°C 下,DBS 中佐匹克隆的初始浓度约为 85%。在两种介质中,ACP 都是以等摩尔量从佐匹克隆形成的。因此,测定佐匹克隆和 ACP 两者可能有助于估计两种介质中的初始浓度。分析前条件对从血液中回收佐匹克隆有重大影响。鉴于其已知的优势,DBS 可以作为从血液中测定佐匹克隆的有价值的替代方法。